Pharmaceutical - Novo Nordisk, Biotechnology

Filter

Current filters:

Novo NordiskBiotechnology

Popular Filters

Patient trust in drugmakers declining, new report shows

14-01-2013

Increasing numbers of pharmaceutical companies are seeking to redefine their relationships with patients,…

Abbott LaboratoriesBiotechnologyEli LillyGilead SciencesGlaxoSmithKlineGlobalJanssenLundbeckMarkets & MarketingNovartisNovo NordiskPfizerPharmaceuticalPricingResearchRoche

Pfizer and Biocon cancel biosimilars deal

14-03-2012

Indian biotech firm Biocon (BSE: 532523) and global drugs behemoth Pfizer (NYSE: PFE) yesterday announced…

Asia-PacificBioconBiotechnologyDiabetesInsulinLicensingNovo NordiskPfizerPharmaceutical

High demand for monoclonal antibodies will drive therapeutic proteins market

22-09-2011

The global therapeutic proteins market will grow at a moderate pace, with monoclonal antibodies considered…

AmgenBiotechnologyGlobalMarkets & MarketingNovo NordiskPharmaceuticalRoche

Company Spotlight

ImmunoGen

ImmunoGen

Back to top